Organizations Announce New Vaccine Guidance Despite HHS Silence

Despite the federal government’s silence on updated vaccine recommendations for the 2026-2027 respiratory virus season, a collection of medical organizations took the initiative upon themselves, according to an NPR report.¹

The American Academy of Pediatrics (AAP), the American College of Obstetricians and Gynecologists (ACOG), the American Academy of Family Physicians (AAFP), and the Infectious Diseases Society of America (IDSA) all issued respective guidelines for patients’ end-of-year immunization plans.

“Vaccination is standard preventive care, and complications can occur in pregnancy as a result of not being vaccinated that are completely preventable,” ACOG President Camille A. Clare, MD, MPH, CPE, FACOG, said in a separate release.² “Unfortunately, we are living in challenging times when it comes to the large amount of vaccine misinformation and disinformation that exists today, so even more responsibility falls to OB-GYNs to combat that and make sure patients know the facts.”

READ MORE: US Disease Tracker Launches to Monitor Vaccine-Preventable Illnesses

The sudden emergence of independent medical guidance follows months of intense federal maneuvering and legal gridlock. In March 2026, a federal lawsuit led by AAP successfully blocked the Trump Administration’s initial efforts to reduce federally recommended routine childhood immunizations.^1,3

Navigating a Fractured Regulatory Landscape

However, the administration revived its vaccine schedule overhaul on August 10, 2026, when President Trump signed Executive Order 14420, establishing the “Gold Standard Childhood Vaccine Recommendations for Americans.” The directive reclassified several core immunizations, including influenza and COVID-19, under a “shared clinical decision-making” category.^4,5

Shortly after the executive order, the Department of Health and Human Services (HHS), under Secretary Robert F. Kennedy Jr, quietly posted a request for information (RFI) to seek public input on whether to revise, delay, or add different vaccine categories to the federal vaccination schedule.^3,5

Analysts warn that HHS may be laying the groundwork to place more vaccines into individualized or conditional categories, which public health experts worry could disrupt the established, routine “machinery of American health care” while complicating insurance coverage mandates.³

What the New Clinical Standards Recommend

To counter federal silence and prevent a vacuum of evidence-based guidance, the Vaccine Integrity Project coordinated a rigorous review of thousands of recent vaccine studies alongside participating medical organizations to ensure clinicians have access to gold-standard clinical safety data.^1,6

In its newly updated policy statement, AAP recommends that all infants and children aged 6 through 23 months receive the 2026-2027 COVID-19 vaccine and advises a single dose for children and adolescents aged 2 to 18 years who are at increased risk of severe disease.⁶

Addressing notable shifts in respiratory disease seasons, ACOG updated its maternal immunization guidelines, extending the eligibility window for the maternal bivalent respiratory syncytial virus (RSV) vaccine, Abrysvo, to run from September 1 through March 1.²

Additionally, the IDSA published rapid clinical guidelines for immunocompromised populations, issuing strong recommendations for age-appropriate COVID-19, influenza, and RSV vaccinations, while emphasizing that coadministering these 3 vaccines is both safe and highly effective for vulnerable patients.⁷

The Role of Pharmacists on the Frontlines

For community pharmacists, navigating this regulatory vacuum requires balance, but professional leaders expect clinical operations to remain steady this season.

Brigid Groves of the American Pharmacists Association noted that because most states have decoupled pharmacists’ authority to immunize from federal guidelines, the upcoming respiratory virus season should largely be “business as usual” with minimal barriers to patient access.¹

Prior to the organizations’ newly announced guidance, Gretchen Garofoli, PharmD, BCACP, CTTS, FAPhA, clinical professor at the West Virginia University School of Pharmacy, pointed out to Drug Topics that the ongoing federal injunction means active pharmacy practices should remain aligned with 2025 standards. However, she was sure to note that public proposals to overhaul vaccine schedules inevitably fuel public confusion and heighten vaccine hesitancy.⁵

To protect patient care, infectious disease specialists are urging clinical pharmacists and providers to submit formal, data-driven feedback to the HHS’ RFI portal before the public comment period closes on September 20, 2026.^3,5

“The problem is that silence at this point is complicit with trying to not make sure people know about the importance of vaccines,” Demetre Daskalakis, MD, MPH, who resigned last year as director of the CDC’s National Center for Immunization and Respiratory Diseases in protest of the agency’s policies under Trump, said to NPR.¹ “The bottom line is that this is dangerous.”

READ MORE: Immunization Resource Center

REFERENCES

1. Stein R. Medical groups offer vaccine guidance to fill federal vacuum. NPR. September 2, 2026. Accessed September 2, 2026. https://www.npr.org/2026/09/02/nx-s1-5947884/covid-flu-rsv-vaccine-recommendations

2. ACOG releases 2026-27 respiratory virus season immunization recommendations for pregnant and postpartum individuals. American College of Obstetricians and Gynecologists. News Release. September 2, 2026. Accessed September 2, 2026. https://www.acog.org/news/news-releases/2026/09/acog-releases-2026-27-respiratory-virus-season-immunization-recommendations

3. Mogensen JF, Cameron C. HHS quietly signals possible changes coming to childhood vaccination schedule. Scientific American. August 25, 2026. Accessed September 2, 2026. https://www.scientificamerican.com/article/trump-administration-quietly-signals-possible-changes-coming-to-childhood-vaccine-schedule/

4. Delivering gold standard childhood vaccine recommendations for Americans. The White House. August 10, 2026. Accessed September 2, 2026. https://www.whitehouse.gov/presidential-actions/2026/08/delivering-gold-standard-childhood-vaccine-recommendations-for-americans/

5. Nowosielski B, Garofoli GK. FAQ: what the RFI on vaccine categories means for pharmacists. September 1, 2026. Accessed September 2, 2026. https://www.drugtopics.com/view/what-the-rfi-on-vaccine-categories-means-for-pharmacists

6. Recommendations for COVID-19 vaccines in infants, children, and adolescents, 2026-2027: policy statement. Pediatrics. 2026; doi: 10.1542/peds.2026-079045

7. Belden K, Nellore A, Goepfert P, et al. IDSA 2026 guidelines on the use of vaccines for the prevention of seasonal COVID-19, influenza, and RSV infections in immunocompromised patients. Infectious Diseases Society of America. September 2, 2026. Accessed September 2, 2026. https://www.idsociety.org/practice-guideline/Seasonal-RTI-Vaccinations-in-Immunocompromised-Patients/